Skip to main content

ORIGINAL RESEARCH article

Front. Neurol.
Sec. Neuromuscular Disorders and Peripheral Neuropathies
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1509174

A patient-centered qualitative evaluation of meaningful change on the NSAA and PUL in

Provisionally accepted
Aviva Gillman Aviva Gillman 1*Teofil Ciobanu Teofil Ciobanu 2Louise Barrett Louise Barrett 1Evan W Davies Evan W Davies 2Alexander P Murphy Alexander P Murphy 3Alex Johnson Alex Johnson 4Jessica Mills Jessica Mills 1Phoebe Heinrich Phoebe Heinrich 1Krystian Przydzial Krystian Przydzial 1Bethany Ewens Bethany Ewens 1Gerrit Vandenberg Gerrit Vandenberg 1Stefan Cano Stefan Cano 1Anna Mayhew Anna Mayhew 5
  • 1 Modus Outcomes, a THREAD Company, London, United Kingdom
  • 2 F. Hoffman-La Roche, Basel, Switzerland
  • 3 Roche Products Ltd, Welwyn Garden City, United Kingdom
  • 4 Duchenne UK, London, United Kingdom
  • 5 John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Hospitals NHS Foundation Trusts, Newcastle upon Tyne, United Kingdom

The final, formatted version of the article will be published soon.

    Duchenne Muscular Dystrophy (DMD) is a rare X-linked genetic disorder caused by mutations in the dystrophin gene. The North Star Ambulatory Assessment (NSAA) and Performance of Upper Limb (PUL) are used to measure motor performance in ambulatory and non-ambulatory individuals, respectively. There is limited published qualitative evidence on what constitutes a meaningful change on either instrument. The aim of this study is to understand what constitutes meaningful change in functional abilities as measured by the NSAA and PUL at different ability levels from the perspective of individuals with DMD, caregivers of individuals with DMD, and clinicians.The study utilized a non-interventional, descriptive, cross-sectional qualitative design consisting of 69 semi-structured interviews, including individuals with DMD (n=18), caregivers of individuals with DMD (n=51), and neuromuscular physiotherapists (n=2) to understand meaningful change on the NSAA and PUL.The results for both instruments indicated that: (i) items that are meaningful differ based on ability level; (ii) maintaining function in lower and upper limbs is the ultimate goal; (iii) meaningful change is often reported in relation to gain or loss of specific function, as opposed to number of total points on the scale; and (iv) losing one scale point corresponds to either a partial or full loss in function and activity, which has differing impacts on daily life.The perception of meaningful change in DMD as measured by the NSAA is influenced by ability levels and ambulatory function, with participants describing their need to maximize certain abilities, maintain function, and retain independence. For the PUL, participants underscored the importance of maintenance of their functional abilities, and highlighted key themes related to maintaining independence in ADLs, reaching, eating/drinking, and finger function for technology use across score categories.

    Keywords: Duchenne muscular dystrophy, patient-reported outcomes, qualitative research, rare disease, Meaningful change

    Received: 10 Oct 2024; Accepted: 29 Jan 2025.

    Copyright: © 2025 Gillman, Ciobanu, Barrett, Davies, Murphy, Johnson, Mills, Heinrich, Przydzial, Ewens, Vandenberg, Cano and Mayhew. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Aviva Gillman, Modus Outcomes, a THREAD Company, London, United Kingdom

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.